BNTC - Benitec Biopharma Limited

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in AUD. All numbers in thousands
Total Revenue4,62011,0934,0543,399
Cost of Revenue45127213940
Gross Profit4,16910,8213,9153,359
Operating Expenses
Research Development6,8906,92513,2876,228
Selling General and Administrative8,7269,09611,7108,142
Non Recurring----
Total Operating Expenses16,26116,51025,42714,410
Operating Income or Loss-11,641-5,417-21,373-11,011
Income from Continuing Operations
Total Other Income/Expenses Net1-273-3,405-498
Earnings Before Interest and Taxes-11,641-5,417-21,373-11,011
Interest Expense----
Income Before Tax-11,640-5,690-24,778-11,509
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-11,640-5,690-24,778-11,509
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-11,640-5,690-24,778-11,509
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-11,640-5,690-24,778-11,509